CalerieHealth™ SOD+NMN is a two-in-one formulation that effectively combines two powerful free-radical scavengers: Superoxide Dismutase (SOD) & Nicotinamide Mononucleotide (NMN). Known as an antioxidant-based mimetic, SOD plays an important role in the body's defense against oxidative stress and is considered to be part of the body's front line of defense for its immune system. Whereas NMN is a derivative of vitamin B3 that is converted by your body into Nicotinamide Adenine Dinucleotide (NAD+), which is necessary for metabolism to convert the food we eat into cellular energy. Overall, NMN & SOD can work together to promote optimal aging, energy metabolism, & immune function.*
Directions
Take three (3) chewable tablets per day with breakfast or between meals on an empty stomach.
Supplement Facts |
Serving Size 3 Chewable Tablets |
Servings Per Container 30 |
Amount Per Serving |
%DV |
|
β-Nicotinamide Mononucleotide (Premium Grade 99.9%) |
360mg* |
CalerieHealth™ Superoxide Dismutase (SOD) 3,600 IU |
72mg* |
Other Ingredients: Inulin, Organic Tapioca Dextrin, Natural Blueberry Flavor, Organic Monk Fruit Extract, Vegetable-Source Magnesium Stearate.
Keep out of reach of children. Keep in a cool, dry place at room temperature. Seek the advice of a healthcare professional prior to use if you are pregnant or taking any medications.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Manufactured & Packed
For CalerieHealth Holding
Address: 200 Spectrum Center Dr, Suite 2100
Irvine, CA 92618
Info at:
www.calerie.com
info@calerie.com
(877) 922-5374
PRODUCT PHOTO
NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.
The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected over dosage, the drug's identity should be verified by chemical analysis.
